Theme: Calcium Handling
|
A |
1o
Hyperparathyroidism |
I |
Osteomalacia |
|
B |
2o
Hyperparathyroidism |
J |
Osteoporosis |
|
C |
3o
Hyperparathyroidism |
K |
PagetŐs Disease |
|
D |
Calcitonin |
L |
Parathyroid Hormone |
|
E |
Calcitriol |
M |
Pseudohypoparathyroidism |
|
F |
Cholecalciferol |
N |
Vitamin D3 |
|
G |
Ergocalciferol |
O |
|
|
H |
Hypoparathyroidism |
P |
|
For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.
1. Disorder of
calcium handling most commonly seen in patients with end-stage chronic renal
failure, in which the plasma calcium is raised.
2. Peptide hormone responsible for
increasing plasma calcium in response to reduced levels by stimulating
osteoclast activity.
3. Form of vitamin D produced following
the action of 1α hydroxylase on 25-OH D3 in the kidney.
4. Which of the
above acts to stimulate 1α hydroxylase activity in the kidney to increase
the production of vitamin D3.
5. The
diagnosis in a patient with a plasma calcium concentration of 2.8mmol/L
(2.2-2.6), a phosphate concentration of 0.76mmol/L (0.8-1.2) and a parathyroid
hormone level of 11.2pmol/L (1.3-7.7).
|
1. C |
2. L |
3. E |
4. L |
5. A |